Bayer MS drug move to cut 540 CA jobs; India busts counterfeit ops on drugmaker premises;

> Bayer HealthCare will cease manufacturing operations for multiple sclerosis drug Betaseron in Emeryville, CA, eliminating about 540 jobs. Article

> Officials in Haryana, India, have busted a counterfeits manufacturing operation at a pharma unit on the premises of Jorker Pharmaceutical. Story

> The Council of the European Union has formally adopted the Directive on Falsified Medicines. Item

> India and Italy are working to bolster their pharma relationship. Report

> U.K.-based CMO SCM Pharma will develop, manufacture and test Speciality European Pharma's oncology product. Story

> Merck South Africa has sold its pharma-manufacturing operations to black-owned investment concern Nkunzi Investment, forming Nkunzi Pharmaceuticals. Article

> Mylan will rebrand its Hyderabad-based subsidiary Matrix Labs as Mylan. Release

> Viagra fakes-distributors taken down: Sarah Knott in Maryland pleaded guilty to trafficking following the discovery by federal agents of 45,684 counterfeit pills; Gene Hardwick of Detroit, less of a brand loyalist, was arrested for his middleman role in sales of phony Viagra and Cialis. News | Item

> Cold chain logistics service provider BioStorage Technologies has opened a 60,000-square-foot facility in Indianapolis.  Story

Suggested Articles

Fujifilm Diosynth Biotechnologies last year committed 10 billion yen toward its manufacturing operations. It has now kicked off one of those projects.

Popular logic says you never switch horses, or CDMOs, in the middle of the stream, but Acacia Pharma had to do that to win an FDA approval.

The FDA has found issues with the testing practices of a U.S. generics maker that had specific problems with ADHD and weight-loss drugs.